Please ensure Javascript is enabled for purposes of website accessibility
ORIGINAL PAPER
Trend analysis of selected classical cardiovascular risk factors in patients with ischemic heart disease in Poland. 10 years’ data of National Registry of Invasive Cardiology Procedures (ORPKI)
 
More details
Hide details
1
Outpatient Treatment Facility ”CenterMed”, Kielce, Poland
 
2
Collegium Medicum, Jan Kochanowski University, Kielce, Poland
 
3
Department of Bioinformatics and Telemedicine, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland
 
4
3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland
 
 
Submission date: 2024-10-15
 
 
Final revision date: 2024-12-19
 
 
Acceptance date: 2025-01-08
 
 
Publication date: 2025-08-13
 
 
Corresponding author
Karol Kaziród-Wolski
Karol Kaziród-Wolski Collegium Medicum Jan Kochanowski University Kielce, Poland
 
 
Medical Studies 2025;41(2):110-118
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Distribution of cardiovascular risk factors can change depending on lifestyle changes.

Aim of the research:
To analyze changes in the prevalence of risk factors over a 10-year period.

Material and methods:
The study included 1,993,262 patients with ischemic heart disease, including 1,035,562 with acute coronary syndrome (ACS) and 959,328 with chronic coronary syndrome (CCS).

Results:
In both groups, there was an increase in male patients undergoing procedures and patients with prior percutaneous coronary intervention (PCI), decrease in the prevalence of diabetes, prior stroke, and prior coronary artery bypass grafting (CABG). In the CCS group, there was an increase in prevalence of previous myocardial infarction (MI), kidney disease, and chronic obstructive pulmonary disease (COPD). In the ACS group, there was an increase in active smokers, patients with prior PCI, and those with COPD. Compared to men, women undergoing these procedures had a higher prevalence of hypertension, diabetes, and kidney disease, but were less likely to be active smokers or had prior stroke, MI, PCI, CABG, psoriasis, or COPD. With advancing age, the prevalence of hypertension, diabetes, kidney disease, COPD, and prior stroke, myocardial infarction, PCI, and CABG increased, while the frequency of active smoking, psoriasis, the proportion of male patients, and body weight decreased.

Conclusions:
Over the past decade the prevalence of risk factors changed significantly. Frequency of previous PCI increased and frequency of previous CABG decreased. Among those undergoing PCI, women more frequently suffered from hypertension and diabetes than men. As age increases, diseases and previous procedures that are risk factors for atherosclerosis accumulated.
REFERENCES (41)
1.
Visseren FLJ, Mach F, Smulders YM, Carballo D, Koski- nas KC, Bäck M, Benetos A, Biffizi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Richard Hobbs FD, Hollander M, Jankowska EA, Michal M, Sac- co S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B. Wytyczne ESC 2021 dotyczące prewencji chorób układu sercowo-naczyniowego w praktyce klinicznej. Kardiol Pol. 2021; 1-122.
 
2.
Lim S, Vos T, Flaxman A, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2224-2260.
 
3.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Prospective Studies Collab-oration. Age-specic relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 1903-1913.
 
4.
Whelton SP, McEvoy JW, Shaw L, Psaty BM, Lima JAC, Budoff M, Nasir K, Szklo M, Blumenthal RS, Blaha MJ. Association of normal systolic blood pressure level with cardiovascular disease in the absence of risk factors. JAMA Cardiol. 2020; 5: 1011-1018.
 
5.
Wang Z, Dong B, Hu J, Adegbija O, Arnold LW. Exploring the non-linear association between BMI and mortality in adults with and without diabetes: the US National Health Interview Survey. Diabet Med. 2016; 33: 1691-1699.
 
6.
Lind M, Svensson AM, Kosiborod M, Gudbjörnsdottir S, Pivodic A, Wedel H, Dahlqvist S, Clements M, Rosen- gren A. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014; 371: 1972-1982.
 
7.
Rawshani A, Sattar N, Franzén S, Rawshani A, Hatter- sley AT, Svensson AM, Eliasson B, Gudbjörnsdottir S. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet. 2018; 392: 477-486.
 
8.
Edqvist J, Rawshani A, Adiels M, Björck L, Lind M, Svensson AM, Gudbjörnsdottir S, Sattar N, Rosengren A. BMI, mortality, and cardiovascular outcomes in type 1 diabetes: findings against an obesity paradox. Diabetes Care. 2019; 42: 1297-1304.
 
9.
Epstein EJ, Osman JL, Cohen HW, Rajpathak SN, Lewis O, Crandall JP. Use of the estimated glucose disposal rate as a measure of insulin resistance in an urban multiethnic population with type 1 diabetes. Diabetes Care. 2013; 36: 2280-2285.
 
10.
van Vliet M, Van der Heyden JC, Diamant M, Von Rosenstiel IA, Schindhelm RK, Aanstoot HJ, Veeze HJ. Overweight is highly prevalent in children with type 1 diabetes and associates with cardiometabolic risk. J Pediatr. 2010; 156: 923-929.
 
11.
Corbin KD, Driscoll KA, Pratley RE, Smith SR, Maahs DM, Mayer-Davis EJ; Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON). Obesity in type 1 diabetes: pathophysiology, clinical impact, and mechanisms. Endocr Rev. 2018; 39: 629-663.
 
12.
Purnell JQ, Zinman B, Brunzell JD. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study. Circulation. 2013; 127: 180-187.
 
13.
DuBose SN, Hermann JM, Tamborlane WV, Beck RW, Dost A, DiMeglio LA, Schwab KO, Holl RW, Hofer SE, Maahs DM; Type 1 Diabetes Exchange Clinic Network and Diabetes Prospective Follow-up Registry. Obesity in youth with type 1 diabetes in Germany, Austria, and the United States. J Pediatr. 2015; 167: 627-632 e1-4.
 
14.
Merger SR, Kerner W, Stadler M, Zeyfang A, Jehle P, Müller-Korbsch M, Holl RW; DPV Initiative; German BMBF Competence Network Diabetes mellitus. Prevalence and comorbidities of double diabetes. Diabetes Res Clin Pract. 2016; 119: 48-56.
 
15.
Shah VN, Grimsmann JM, Foster NC, Dost A, Miller KM, Pavel M, Weinstock RS, Karges W, Maahs DM, Holl RW. Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network (United States) and the prospective diabetes follow-up (Germany/Austria) registries. Diabetes Obes Metab. 2020; 22: 1577-1585.
 
16.
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Ja- far TH, Lambers Heerspink HJ, Mann JF, Matsushita K, Wen CP. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013; 382: 339-352.
 
17.
Matsushita K, van der Velde M, Astor BC. Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010; 375: 2073-2081.
 
18.
Wanner C, Amann K, Shoji T. The heart and vascular system in dialysis. Lancet. 2016; 388: 276-284.
 
19.
Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015; 3: 631-639.
 
20.
Vaneteren LE, Spruit MA, Wouters EFM, Franssen FME. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med. 2016; 4: 911-924.
 
21.
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis J, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fernández-Solà J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, Kassebaum N, Koroshetz W, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Mo- ran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes de Oliveira G, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro AL, Rigotti N, Rodgers A, Sa- ble C, Shakil S, Sliwa-Hahnle K, Stark B, Sundström J, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whel- ton PK, Yacoub M, Zuhlke L, Murray C, Fuster V; GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020; 76: 2982-3021.
 
22.
Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014; 383: 999-1008.
 
23.
Mensah GA, Wei GS, Sorlie PD, Fine LJ, Rosenberg Y, Kaufmann PG, Mussolino ME, Hsu LL, Addou E, Engelgau MM, Gordon D. Decline in cardiovascular mortality: possible causes and implications. Circ Res. 2017; 120: 366-380.
 
24.
Jousilahti P, Laatikainen T, Salomaa V, Pietilä A, Vartiainen E, Puska P. 40-year CHD mortality trends and the role of risk factors in mortality decline: the North Karelia project experience. Glob Heart. 2016; 11: 207-212.
 
25.
Wolska M, Peruzzi M, Kaziród-Wolski K, Wróbel P, Oleś I, Sielski J, Jankowski P. Risk factors for cardiovascular diseases: the focus on primary prevention. Minerva Cardiol Angiol. 2025; 73: 245-253.
 
26.
Sławska A, Siudak Z. Fear of death in acute coronary syndromes – incidence and predictors. Med Stud. 2018; 34: 304-308.
 
27.
Wiraszka G, Głuszek-Osuch M, Stępień R. Incidence and determinants of chronic stress as a health risk factor in a group of Polish high school students. Med Stud. 2024; 40: 102-112.
 
28.
Masaebi F, Salehi M, Kazemi M, Vahabi N, Looha MA, Zayeri F. Trend analysis of disability adjusted life years due to cardiovascular diseases: results from the global burden of disease study 2019. BMC Public Health. 2021; 21: 1268.
 
29.
Zdrojewski T, Rutkowski M, Bandosz P, Gaciong Z, Jędrzejczyk T, Solnica B, Pencina M, Drygas W, Wojty- niak B, Grodzicki T, Piwoński J, Wyrzykowski B. Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NATPOL 2011 Survey. Kardiol Pol. 2013; 71: 381-392.
 
30.
Trzeciak P, Wożakowska-Kapłon B, Niedziela J, Gierlo- tka M, Hawranek M, Lekston A, Wasilewski J, Poloński L, Gąsior M. Comparison of inhospital and 12- and 36-month outcomes after acute coronary syndrome in men versus women <40 years (from the PL-ACS Registry). Am J Cardiol. 2016; 118: 1300-1305.
 
31.
Piątek Ł, Wilczek K, Kurzawski J, Gierlotka M, Gąsior M, Poloński L, Sadowski M. Gender-related disparities in the treatment and outcomes in patients with non-ST-segment elevation myocardial infarction: results from the Polish Registry of Acute Coronary Syndromes(PL-ACS) in the years 2012-2014. Arch Med Sci. 2020; 16: 781-788.
 
32.
Piątek Ł, Janion-Sadowska A, Piątek K, Zandecki Ł, Kurzawski J, Gąsior M, Sadowski M. The progress in outcomes of the management of patients with non-ST-segment elevation myocardial infarction between 2005 and 2014 in Poland – a propensity score matching analysis from the PL-ACS registry. Adv Interv Cardiol. 2020; 16: 41-48.
 
33.
Dziewierz A, Zdzierak B, Malinowski KP, Siudak Z, Zasada W, Tokarek T, Zabojszcz M, Dolecka-Ślusarczyk M, Dudek D, Bartuś S, Surdacki A, Rakowski T. Diabetes mellitus is still a strong predictor of periprocedural outcomes of primary percutaneous coronary interventions in patients presenting with ST-segment elevation myocardial infarction (from the ORPKI Polish National Registry). J Clin Med. 2022; 11: 6284.
 
34.
Kringeland E, Tell GS, Midtbø H, Igland J, Haugsgjerd TR, Gerdts E. Stage 1 hypertension, sex, and acute coronary syndromes during midlife: the Hordaland Health Study. Eur J Prev Cardiol. 2022; 29: 147-154.
 
35.
McCullough PA. Acute coronary syndromes in patients with renal failure. Curr Cardiol Rep. 2003; 5: 266-270.
 
36.
Siudak Z, Wysocka-Dubielecka K, Malinowski K, Dziewierz A, Tokarek T, Plens K, Dudek D. Psoriasis is an independent predictor of increased risk of allergic reaction during percutaneous coronary interventions. Big data analysis from the Polish National PCI Registry (ORPKI). Cardiol J. 2020; 27: 278-284.
 
37.
Rębak D, Suliga E, Głuszek-Osuch M, Głuszek S. Risk factors of cardiovascular diseases in paramedics. Med Stud. 2017; 33: 279-289.
 
38.
https://isap.sejm.gov.pl/isap..... Accessed: 18th October 2024.
 
39.
https://isap.sejm.gov.pl/isap..... Accessed: 18th October 2024.
 
40.
https://isap.sejm.gov.pl/isap..... Accessed: 18th October 2024.
 
41.
https://baw.nfz.gov.pl/NFZ/doc.... Accessed: 18th October 2024.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top